Three FDA representatives discuss new drug indications, safety precautions and label changes, & an emergency program to rapidly evaluate existing immunomodulating therapies for use in COVID-19 patients.
Susan Bernstein is a freelance journalist based in Atlanta. She earned a Bachelor of Arts degree in English from the University of Florida in Gainesville, Fla. Susan has worked as a professional journalist, writer, book author and editor for 25 years. She served in full-time positions with both the Arthritis Foundation and the American College of Rheumatology. She began working as a freelance journalist in 2011. Susan is the author of numerous Web and print articles on a variety of medical topics and is the author of three patient health books published by the Arthritis Foundation.
Articles by Susan Bernstein
Telerheumatology: What’s Next?
In an ACR Convergence session, two rheumatologists discussed how COVID-19 changed the use of telemedicine, how payers reacted and which changes are likely permanent and which are likely to be temporary.
Osteoporosis Experts Discuss Bisphosphonate Holidays
ACR CONVERGENCE 2020—Bisphosphonates are an important treatment for millions of older Americans with osteoporosis because the drugs inhibit osteoclastic bone resorption to reduce the risk of painful, debilitating fractures.1 More than 20 years ago, data emerged that bisphosphonates have a long terminal half-life.2 So after years of therapy, could some patients take a drug holiday?…
Food for Thought: On Eating & Inflammation in Rheumatic Disease
Certain nutrients or dietary patterns may affect inflammation and rheumatic disease risk in certain populations. Recommended nutrients include omega-3 fatty acids found in fish, poultry or nuts. Following a Mediterranean or standard Western diet may affect RA risk too.
Diversity: From Concepts to Outcomes
ACR CONVERGENCE 2020—In 2020, terms like unconscious bias, diversity and inclusivity are buzzwords in rheumatology, as well as throughout American society. The COVID-19 pandemic revealed stark disparities in healthcare outcomes for rheumatic disease patients of racial and ethnic minorities, including new research that shows Black and Latinx patients have a higher risk of hospitalization and…
Inaugural ACR Distinguished Global Public Health Award Presented to Dr. Fauci
ACR CONVERGENCE 2020—At the ACR’s fully virtual annual meeting on Saturday, Nov. 7, ACR President Ellen M. Gravallese, MD, chief of the Division of Rheumatology, Inflammation and Immunity at Brigham and Women’s Hospital, Boston, presented the inaugural ACR Distinguished Global Public Health Award to Anthony S. Fauci, MD, director of the National Institute of Allergy…
Dr. Fauci Talks COVID-19 with the ACR
ACR CONVERGENCE 2020—At the ACR’s fully virtual annual meeting on Saturday, Nov. 7, Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID) since 1984, delivered a special lecture on COVID-19, from virology to therapy to vaccine development. Novel Coronavirus, Familiar Vectors When Chinese physicians first reported infections by what…
COVID-19: Practical Tips for Practices
The ACR’s July 13 online town hall, “COVID-19 Guidance for Community Practices,” covered telehealth, safe clinic reopening and Department of Health & Human Services loans.
Telemedicine & Fellowship Education After COVID-19: Q&A with Kanika Monga, MD
The COVID-19 pandemic is reshaping clinical rheumatology and the fellowship experience. Rheumatology education should include how to triage patients for remote visits, says second-year fellow Kanika Monga, MD…
The ACR Releases a New Gout Guideline
In May, the ACR released a new treatment guideline for the management of gout for simultaneous publication in Arthritis & Rheumatology and Arthritis Care & Research.1 Based on evidence from more than 130 published studies, the guideline makes a total of 42 recommendations—of which 16 are strong: It has 27 recommendations for urate-lowering therapy (ULT)…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 20
- Next Page »